The CEO of Stoke Therapeutics began his career treating rare pediatric genetic diseases. From there he joined Genzyme, then Sarepta Therapeutics before assuming his current role in 2018.
Source link
La Potencia Mas Caliente
The CEO of Stoke Therapeutics began his career treating rare pediatric genetic diseases. From there he joined Genzyme, then Sarepta Therapeutics before assuming his current role in 2018.
Source link